Clinical trial
A Pilot Study on the Efficacy of DTG Plus 3TC for Prophylaxis of Mother-to-child Transmission of HIV Infection in Pregnant Women Who Have Detectable Viral Load After 14 Weeks of Gestation
NCT04808973 is registered in ClinicalTrials.gov with Fundação Bahiana de Infectologia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study on the Efficacy of DTG Plus 3TC for Prophylaxis of Mother-to-child Transmission of HIV Infection in Pregnant Women Who Have Detectable Viral Load After 14 Weeks of Gestation
- Lead sponsor
- Fundação Bahiana de Infectologia
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 1, 2021
- Completion date
- September 10, 2023
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv infections, mother to child transmission, pregnancy related